Feb 27, 2017 21:05 pm UTC| Business
SOLUTION study with Sollpura™ missed non-inferiority endpoint by 1%, prompting new phase 3 studyData Monitoring Committee issued recommendation to continue SIMPLICITY study with Sollpura™Blisibimod for the treatment of IgA...
Feb 27, 2017 21:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 27, 2017 -- Global Blood Therapeutics, Inc.(GBT) (NASDAQ:GBT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat grievous...
Feb 27, 2017 21:05 pm UTC| Business
IRVINE, Calif., Feb. 27, 2017 -- The Habit Restaurants, Inc. (Nasdaq:HABT), ("The Habit"), today announced that Russell Bendel, chief executive officer, and Ira Fils, chief financial officer, will be presenting at the...
Feb 27, 2017 21:05 pm UTC| Business
MENLO PARK, Calif., Feb. 27, 2017 -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to identifying, developing and commercializing innovative, differentiated therapies to improve the lives of...
Fulgent Genetics Reports Fourth Quarter and Full Year 2016 Financial Results
Feb 27, 2017 21:05 pm UTC| Business
Fourth Quarter Revenue doubles year over year to $5.9 Million and reaches $18.3 Million for the Full Year of 2016Fourth Quarter 2016 GAAP Income totals $0.8 Million, or $0.05 per ShareFourth Quarter 2016 Non-GAAP Income...
Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2016
Feb 27, 2017 21:05 pm UTC| Business
~ Provides Business Outlook for Full Year 2017 ~ Note: A webcast of Integer’s conference call and accompanying presentation slides will be available at 5:00 p.m. EST today athttp://investor.integer.net. FRISCO,...
Kona Grill Reports Fourth Quarter 2016 Results
Feb 27, 2017 21:05 pm UTC| Business
SCOTTSDALE, Ariz., Feb. 27, 2017 -- Kona Grill, Inc. (NASDAQ:KONA), an American grill and sushi bar, reported financial results for the fourth quarter and year ended December 31, 2016. The Company also initiated 2017...